Results 251 to 260 of about 106,594 (302)
Gut microbiota dysbiosis and metabolic abnormalities promote oxidative stress and fibrosis in idiopathic pulmonary fibrosis. [PDF]
Sci RepBai B +6 more
europepmc +1 more source
Integrative Machine Learning and Structural Modeling Identify Multitarget Therapeutic Candidates for Idiopathic Pulmonary Fibrosis. [PDF]
ACS OmegaDing R, Zhang Y.
europepmc +1 more source
Integrated transcriptomic and metabolomic profiling reveals immune-metabolic crosstalk and predictive biomarkers of ligustrazine treatment response in idiopathic pulmonary fibrosis. [PDF]
J Transl MedBao Y +5 more
europepmc +1 more source
The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis. [PDF]
Int J Mol SciGhio AJ, Sangani RG, Todd NW.
europepmc +1 more source
Research Progress on the Mechanisms of Gut Microbiota Dysbiosis Associated With Idiopathic Pulmonary Fibrosis: A Review. [PDF]
CureusLi X, Xu S, Li Y, Wang R, Qin C, Wang X.
europepmc +1 more source
Genes, gut microbiome, and lungs: Untangling the web of Idiopathic Pulmonary Fibrosis
Hernandez-Beeftink T +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2018
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.
David J Lederer, Fernando J Martinez
exaly +8 more sources
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.
David J Lederer, Fernando J Martinez
exaly +8 more sources
New England Journal of Medicine, 2001
Idiopathic pulmonary fibrosis is a rapidly progressive illness of unknown cause characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Treatment at present remains largely supportive, with evidence that patients' satisfaction and survival may be improved by referral to centers specializing in the evaluation ...
T J Gross, G W Hunninghake
exaly +3 more sources
Idiopathic pulmonary fibrosis is a rapidly progressive illness of unknown cause characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Treatment at present remains largely supportive, with evidence that patients' satisfaction and survival may be improved by referral to centers specializing in the evaluation ...
T J Gross, G W Hunninghake
exaly +3 more sources
Seminars in Respiratory and Critical Care Medicine, 2012
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M, Adkins, Harold R, Collard
openaire +4 more sources
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M, Adkins, Harold R, Collard
openaire +4 more sources